Gillian Cannon, Director of Xenon Pharmaceuticals XENE, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $63.2K. The latest trade was on 06/05.

GC

GC

Gillian Cannon

Director

Company

Xenon Pharmaceuticals XENE

First filing

23/05/23

Trades

16 trades

Buys / sales

0 / 1

12-month net buying

−$63.2K

Last trade

06/05

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xenon PharmaceuticalsXENE	Open-market sale10b5-1 plan	06/05	06/08	1,190 sh	$53.14	$63,236.6	−45.0%